Showing results (1381-1390 of 2,791) with videos related to

Sort By:
Pageof 280
Cytotherapy|June 4, 2026
A novel method for efficient murine regulatory T-cell expansion and retroviral transductionCameron McDonald-Hyman, Pooja Shree Marri Baskar, Yiyun Peng, et al.
Cytotherapy|June 4, 2026
Rethinking CAR-T manufacturing paradigms: terminology, operational considerations, and economic trade-offsChase McCann, Jacob Matriccino, Mark Lowdell, et al.
Cytotherapy|June 5, 2026
Overcoming five main challenges to targeting hematologic malignanciesMegha Thakkar, Patrick J Hanley, Alexey Bersenev, et al.
Cytotherapy|July 27, 2023
Cell and gene therapy workforce development: the role of the International Society for Cell & Gene Therapy (ISCT) in the creation of a sustainable and skilled workforce in EuropeJoaquim Vives, Fermín Sánchez-Guijo, Massimiliano Gnecchi, et al.
Cytotherapy|July 22, 2023
A distinct cytokine network distinguishes chimeric antigen receptor T cell (CAR-T)-associated hemophagocytic lymphohistiocytosis-like toxicity (carHLH) from severe cytokine release syndrome following CAR-T therapyCheng Zu, Shenghao Wu, Mingming Zhang, et al.
Cytotherapy|June 18, 2023
Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysisAlexandre G Troullioud Lucas, Caroline A Lindemans, Senthil Velan Bhoopalan, et al.
Cytotherapy|June 24, 2023
High-mobility group box 1 accelerates distraction osteogenesis healing via the recruitment of endogenous stem/progenitor cellsQi Chang, Masahito Fujio, Makoto Tsuboi, et al.
Cytotherapy|June 9, 2023
Mini-review: Equipment evaluation for process scalability and readiness for current Good Manufacturing Practices in cell therapy workflowsMaetja Verbarendse, Richard Snyder, Uma Lakshmipathy
Cytotherapy|April 3, 2026
Improved lentivector-modified hematopoietic stem cell transplantation in the Townes mouse model of sickle cell diseaseTheresa A Dlugi, Juliana Alvarez-Argote, Teresa Sundararajan, et al.
Cytotherapy|April 3, 2026
A first-in-human phase I clinical trial investigating the safety and efficacy of repeat dosing MSCTRAIL cell therapy in addition to chemotherapy and immunotherapy in patients with advanced lung cancerRebecca N Graham, Alice Davies, Monica L Mullin, et al.
Pageof 280